Riskpilot← Back to searchSign inGet full accessDERMANOR AS
ASActiveOrg 871585342Billingstadsletta 19A, 1396 BillingstadWholesale of perfume and cosmetics · NACE 4645Est. 199425 employees
Revenue 2024
NOK 139,5M
-39% vs 2023
EBITDA margin
-0.2%
-102% vs 2023
Equity ratio
14.8%
Financial strength
Net profit 2024
NOK -5,1M
-116% vs 2023
| Revenue | NOK 139,5M | -39% |
| EBITDA | NOK -278K | -102% |
| Net profit | NOK -5,1M | -116% |
| Total assets | NOK 131,4M | -16% |
| Equity | NOK 19,4M | -21% |
| Employees | 25 | — |
Legal name
DERMANOR AS
Org number
871585342
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
14. desember 1994
Share capital
NOK 3 000 000
Employees
25 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Handel med hudpleieartikler og hva som står i forbindelse med dette. Selskapet kan ved innskudd eller på annen måte interessere seg i andre foretagender.
Address
Billingstadsletta 19A, 1396 Billingstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201 106 | 0 | 0 | 233 116 | 213 494 | 169 419 | 116 898 | 123 291 | 125 180 | 200 932 | 263 550 | 251 256 | 228 438 | 139 482 |
| Staff expenses | −49 127 | −0 | −0 | −49 458 | −44 579 | −32 350 | −27 474 | −28 891 | −30 277 | −35 708 | −44 298 | −47 468 | −47 797 | −33 047 |
| EBITDA | 27 990 | 0 | 0 | −6 906 | 24 892 | 20 511 | 7 170 | 10 207 | 10 922 | 39 041 | 36 348 | 25 419 | 11 642 | −278 |
| Depreciation & amort. | −1 912 | −0 | −0 | −2 466 | −2 789 | −2 327 | −2 327 | −1 998 | −1 032 | −1 502 | −3 122 | −4 683 | −5 416 | −4 461 |
| EBIT | 26 078 | 0 | 0 | −9 372 | 22 104 | 18 184 | 4 843 | 8 210 | 9 890 | 37 539 | 33 226 | 20 736 | 6 226 | −4 740 |
| Net financials | 13 286 | 0 | 0 | −142 | −212 | −140 | 15 018 | 14 207 | 16 441 | 1 563 | 31 067 | 26 964 | 29 049 | −859 |
| Profit before tax | 39 364 | 0 | 0 | −9 513 | 21 892 | 18 044 | 19 861 | 22 417 | 26 331 | 39 102 | 64 293 | 47 701 | 35 275 | −5 598 |
| Tax | 8 508 | −0 | −0 | −2 700 | 5 615 | 4 397 | 1 387 | 2 070 | 2 530 | 8 615 | 7 500 | 3 953 | 3 292 | −524 |
| Net profit | 30 856 | 0 | 0 | −6 814 | 16 276 | 13 647 | 18 474 | 20 347 | 23 801 | 30 487 | 56 793 | 43 748 | 31 983 | −5 075 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 201 231 | — | — | 157 074 | 153 538 | 161 552 | 158 616 | 145 505 | 150 798 | 171 871 | 203 066 | 157 125 | 155 696 | 131 439 |
| Equity | 63 203 | — | — | 61 916 | 83 248 | 96 879 | 96 897 | 96 748 | 96 605 | 104 762 | 23 385 | 24 410 | 24 520 | 19 445 |
| Long-term debt | 62 919 | 0 | 0 | 51 666 | 40 040 | 41 959 | 18 529 | 4 191 | 2 466 | 1 726 | 1 163 | 742 | 39 912 | 67 410 |
| Short-term debt | 75 110 | 0 | 0 | 43 492 | 30 250 | 22 714 | 43 191 | 44 566 | 51 727 | 65 383 | 178 518 | 131 973 | 91 264 | 44 584 |
| Total debt | 138 029 | 0 | 0 | 95 158 | 70 290 | 64 673 | 61 719 | 48 757 | 54 193 | 67 109 | 179 681 | 132 715 | 131 176 | 111 994 |
EBITDA margin
-0.2%
This company
15.8%
Market median
-101% vs market
20112024
Equity ratio
14.8%
This company
38.2%
Market median
-61% vs market
20112024
Return on equity
-26.1%
This company
18.4%
Market median
-242% vs market
20112024
Net profit margin
-3.6%
This company
8.1%
Market median
-144% vs market
20112024
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
20112024
Debt / equity
5.76×
This company
0.62×
Market median
-829% vs market
20112024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HN Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Derma Nordic As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tricolor As
DERMANOR AS Board members of DERMANOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henning Nielsen | Chief Executive Officer | 0 companies |
| Christian Ringnes | Chairman | 0 companies |
| Jørn Aage Johansen | Board of Directors | 0 companies |